Warning Letter — Delight Distribution Inc.
The FDA issued a Warning Letter to Delight Distribution Inc. following an evaluation by the Office of Inspections and Investigations. The letter follows an inspection that identified regulatory violations, though specific product-level details are not provided in the source excerpt.
This action affects Delight Distribution Inc., its management, and personnel responsible for regulatory compliance, quality systems, and distribution operations.
This enforcement action suggests significant deviations from FDA requirements that remained unresolved following an inspection. For regulatory professionals, this underscores the importance of the Office of Inspections and Investigations' oversight role and indicates that the firm's current controls likely failed to meet the agency's standards for distribution compliance.
Review internal audit procedures to ensure compliance with federal distribution standards and confirm that all necessary registrations or product listings are currently valid and accurate. Ensure responsiveness to FDA inspection findings to prevent escalation to a Warning Letter.
FDA Warning Letter issued to: Delight Distribution Inc.. 06/08/2026 — Office of Inspections and Investigations. Source: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/delight-distribution-inc-731390-06082026
Open in openFDA / FDA.gov